The FDA’s PAT (Process Analytical Technology) initiative has enabled GEA to combine its equipment design skills and process engineering know-how in order to integrate online analyzers and measurement devices into its process systems in a way which can provide real insight into the operation of the process and help customers achieve key product quality target.

The goal of the PAT initiative is to ensure that products are manufactured using processes which are understood and monitored so that the key quality characteristics of the products can be actively controlled.
Combining process monitoring using online analyzers, together with solid process engineering principles and advanced process modelling techniques will enable processes to be actively controlled in order to compensate for minor input variations (e.g. raw materials) so that the specifications for the final product will be closer to the ideal target.